WASHINGTON (AP) — Amgen Inc. has won federal approval for the second medicine in a new class of pricey biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that h…
Search Results - The Southern, The Southern: Living
Thu, 08/27/2015 - 3:12pm